Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer: A Single-Institution Long Follow-Up Cohort Study

Immunotherapy with Bacillus Calmette–Guérin (BCG) is the most efficacious treatment for high-risk bladder cancer (BC) (Ta/T1 or carcinoma in situ) to reduce the risk of recurrence. Our aim was to evaluate whether hypertension and diabetes influence the outcome of patients with noninvasive BC treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Moro, Fabrizio, Bovo, Alberto, Crestani, Alessandro, Vettor, Roberto, Gardiman, Marina P., Zattoni, Filiberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553954/
https://www.ncbi.nlm.nih.gov/pubmed/25738480
http://dx.doi.org/10.1097/MD.0000000000000589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553954/
https://www.ncbi.nlm.nih.gov/pubmed/25738480
http://dx.doi.org/10.1097/MD.0000000000000589

Ejemplares similares